Surgery May Beat Medicines For Hard-To-Treat Childhood Epilepsy

What was studied

This study did not follow real children in a trial. Instead, it used a decision model to compare 3 treatment approaches for children with drug-resistant focal epilepsy: continued medical management, open resective surgery, and MRI-guided laser interstitial thermal therapy (MRgLITT), a minimally invasive laser procedure.

The model represented a hypothetical group of 10-year-old children in the United States with drug-resistant focal epilepsy and a seizure focus smaller than 3 cm3. The researchers used data from published systematic reviews, meta-analyses, and cohort studies to estimate lifetime survival, quality-adjusted life years, and direct medical costs.

What they found

In the model, both surgery options were associated with better outcomes than medical management alone. Compared with medical management, the surgical strategies were associated with about a 4.6-year survival advantage, about 3.6 additional lifetime quality-adjusted life years, and lower lifetime medical costs.

MRgLITT and open resection had very similar results overall. MRgLITT was estimated at 22.64 quality-adjusted life years and $120,943 in lifetime costs, while open resection was 22.62 quality-adjusted life years and $121,650. Medical management was estimated at 19.00 quality-adjusted life years and $127,471. In probabilistic sensitivity analysis, neither surgery showed clear superiority overall.

In etiology-specific analyses, the model favored MRgLITT for focal cortical dysplasia and mesial temporal sclerosis, and favored open resection for tumor-related and cavernoma-related epilepsy.

Limits of the evidence

This was a modeling study, not a randomized clinical trial. Its results depend on the quality of the earlier studies and the assumptions built into the model.

The participants were hypothetical 10-year-old children with a small seizure focus, so the findings may not apply to children of other ages, larger seizure areas, or other epilepsy types. The abstract also does not provide detailed information about complications, recovery, neurodevelopment, or family preferences. Because the difference between MRgLITT and open resection was very small, the study does not show clear overall superiority of one over the other.

For families and caregivers

For families, this study supports considering early surgical referral for children with drug-resistant focal epilepsy, rather than relying only on medicines when seizures continue.

It also suggests that the choice between laser treatment and open surgery may depend more on the epilepsy etiology than on a large difference in overall long-term effectiveness. This may help families ask more specific questions during a surgical evaluation.

What to watch next

Useful next steps would include studies that directly compare MRgLITT and open surgery in similar children and also assess outcomes such as seizure control, complications, neurodevelopment, and quality of life.

Terms in this summary

drug-resistant epilepsy

Epilepsy in which seizures continue despite trying appropriate seizure medicines.

focal epilepsy

Epilepsy in which seizures start in one specific area of the brain.

MRgLITT

A minimally invasive procedure that uses MRI guidance and heat from a laser to treat a small seizure-causing area in the brain.

open resection

Brain surgery that removes the area causing seizures through an opening in the skull.

quality-adjusted life year (QALY)

A measure that combines how long a person lives with the quality of that life.

Markov decision model

A model that estimates long-term outcomes by simulating different health paths over time.

mesial temporal sclerosis

Scarring in a deep part of the temporal lobe that can be associated with seizures.

cavernoma

A cluster of abnormal blood vessels in the brain that can be associated with seizures.